Aim: The 20(S)-ginsenoside Rh2 (Rh2) is being developed as a new antitumor drug. However. to date. little is known about the kinetics of its deglycosylation metabolite (protopanoxadiol) (PPD) following Rh2 administration. https://www.opheliasmuse.com/